← Leaderboards
Corrine K Welt
Massachusetts General Hospital
$6,308,123
Attributed
$6,308,123
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $651.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,869,331 · 15
FDA$438,792 · 1
By mechanism
R01$5,293,989 · 4
M01$714,134 · 11
R56$300,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joel S Finkelstein$18,947,740
- Madhusmita Misra$12,646,884
- Karen K Miller$23,499,917
- David Pepin$2,535,692
- Benjamin Z Leder$7,400,681
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemaleAffectWomanInfertilityGeneticGenesEtiologyMenstrual CycleCohortPhenotypeMutationVariantSyndromeGenetic TranscriptionDatabasesPathway InteractionsFamilyTranslationsPrimary Ovarian InsufficiencyOvaryBaseProteinsPremature MenopauseGenome Wide Association Study
Grant awards (34)
Comorbid Disease in Women with Primary Ovarian Insufficiency$558,419
R01 · FY2025 · HD · contact PI
Primary Ovarian Insufficiency: Etiology and Comorbid Disease$317,581
R01 · FY2023 · HD · contact PI
Translational Control in Oogenesis and Embryogenesis$321,317
R01 · FY2022 · HD · contact PI
Primary Ovarian Insufficiency: Etiology and Comorbid Disease$317,581
R01 · FY2022 · HD · contact PI
Translational Control in Oogenesis and Embryogenesis$321,317
R01 · FY2021 · HD · contact PI
Primary Ovarian Insufficiency: Etiology and Comorbid Disease$317,581
R01 · FY2021 · HD · contact PI
Translational Control in Oogenesis and Embryogenesis$327,875
R01 · FY2020 · HD · contact PI
Primary Ovarian Insufficiency: Etiology and Comorbid Disease$324,063
R01 · FY2020 · HD · contact PI
Primary Ovarian Insufficiency: Etiology and Comorbid Disease$324,063
R01 · FY2019 · HD · contact PI
The Genetics of Primary Ovarian Insufficiency$300,000
R56 · FY2017 · HD · contact PI
The Genetics of Polycystic Ovary Syndrom$337,941
R01 · FY2014 · HD · contact PI
The Genetics of Polycystic Ovary Syndrom$329,945
R01 · FY2013 · HD · contact PI
The Genetics of Polycystic Ovary Syndrom$347,676
R01 · FY2012 · HD · contact PI
The Genetics of Polycystic Ovary Syndrom$347,676
R01 · FY2011 · HD · contact PI
The Genetics of Polycystic Ovary Syndrom$362,162
R01 · FY2010 · HD · contact PI
RECOMBINANT HUMAN PROLACTIN FOR LACTATION INDUCTION/ PROLACTIN DEFICIENT MOTHERS$5,666
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: THE EFFECT OF PROLACTIN ON LACTATION$1,781
M01 · FY2008 · RR · contact PI
THE EFFECT OF PROLACTIN ON LACTATION$962
M01 · FY2008 · RR · contact PI
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency$219,396
R01 · FY2007 · FD · contact PI
THE EFFECT OF PROLACTIN ON LACTATION$6,449
M01 · FY2007 · RR · contact PI
THE EFFECT OF PROLACTIN ON LACTATION$4,501
M01 · FY2007 · RR · contact PI
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency$219,396
R01 · FY2006 · FD · contact PI
THE EFFECT OF PROLACTIN ON LACTATION$3,956
M01 · FY2006 · RR · contact PI
URINE TESTING FOR POLYCYSTIC OVARY SYNDROME$3,696
M01 · FY2006 · RR · contact PI
THE EFFECT OF PROLACTIN ON LACTATION$2,411
M01 · FY2005 · RR
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency$0
R01 · FY2005 · FD
THE EFFECT OF PROLACTIN ON BONE TURNOVER$65,816
M01 · FY2004 · RR
THE EFFECT OF PROLACTIN ON THE FEMALE REPRODUCTIVE AXIS$16,592
M01 · FY2004 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$200,768
M01 · FY2002 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$200,768
M01 · FY2002 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$200,768
M01 · FY2001 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$0
M01 · FY2001 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$0
M01 · FY2000 · RR
Regulation of Ovarian Dimeric Inhibin Secretion$0
M01 · FY2000 · RR